{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:22:14Z","timestamp":1789363334258,"version":"build-2803163510"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T00:00:00Z","timestamp":1340064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Although acne vulgaris is common in preadolescents (&lt;13\u2003yrs), few acne treatments are currently approved for children. This study assessed the safety and efficacy of tretinoin microsphere gel (TMG) 0.04% pump in children aged 9\u201311 with acne vulgaris. In this multicenter, randomized, double\u2010blind, vehicle\u2010controlled pilot study, patients applied TMG 0.04% pump or vehicle once daily to the face for 12\u2003weeks. Efficacy measures were changes in facial lesion counts, Investigator Global Evaluation of acne severity using two scales, and Investigator Global Assessment of Improvement from baseline to week 12. Of the 110 patients enrolled, 55 received TMG 0.04% pump, and 55 received vehicle. At week 12, there was significantly greater improvement in the least\u2010squares mean change in noninflammatory lesions with TMG 0.04% than with vehicle (\u221219.9 vs \u22129.7, p\u2003=\u20030.04) and a significant difference in Investigator Global Assessment of improvement at week 12 between the children treated with TMG 0.04% pump and those treated with vehicle (p\u2003=\u20030.02), but there were no discernible differences in static acne severity scales. Change from baseline in signs and symptoms of cutaneous irritation were similar between the active and vehicle arms at week 12. This study demonstrated statistically significant differences in the reduction of noninflammatory lesions between TMG 0.04% pump and vehicle in patients aged 9\u201311 with acne vulgaris. Additional studies are warranted to further characterize the safety and efficacy of TMG 0.04% pump for the treatment of acne in the preadolescent population.<\/jats:p>","DOI":"10.1111\/j.1525-1470.2012.01811.x","type":"journal-article","created":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T02:23:16Z","timestamp":1340158996000},"page":"598-604","source":"Crossref","is-referenced-by-count":12,"title":["Tretinoin Microsphere Gel 0.04% Pump for Treating Acne Vulgaris in Preadolescents: A Randomized, Controlled Study"],"prefix":"10.1111","volume":"29","author":[{"given":"Lawrence F.","family":"Eichenfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide A.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Schachner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatris","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.","family":"Lucky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,19]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70442-6"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6682.1217"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02510.x"},{"key":"e_1_2_8_5_2","first-page":"287","article-title":"Prevalence of acne vulgaris in Auckland senior high school students","volume":"108","author":"Lello J","year":"1995","journal-title":"N Z Med J"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2006.00076.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02036.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1997.tb00420.x"},{"issue":"3","key":"e_1_2_8_9_2","first-page":"2","article-title":"Prepubertal acne: clinical presentation, evaluation, and treatment","volume":"2","author":"Marcoux D","year":"1998","journal-title":"J Cutan Med Surg"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000067819"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2006.045377"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017838"},{"key":"e_1_2_8_13_2","first-page":"24","article-title":"Acne: intervene early","volume":"31","author":"Roebuck HL","year":"2006","journal-title":"Nurse Pract"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.618"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2004.03.010"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.02.009"},{"key":"e_1_2_8_17_2","first-page":"1129","article-title":"Phase 4 study to assess tretinoin pump for the treatment of facial acne","volume":"7","author":"Eichenfield LF","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546631003681094"},{"key":"e_1_2_8_19_2","first-page":"152","article-title":"A double\u2010blinded, randomized, vehicle\u2010controlled, multicenter, parallel\u2010group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults","volume":"80","author":"Berger R","year":"2007","journal-title":"Cutis"},{"key":"e_1_2_8_20_2","first-page":"s2","article-title":"Tretinoin microsphere gel in facial acne vulgaris: a meta\u2010analysis","volume":"7","author":"Nighland M","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_21_2","first-page":"650","article-title":"Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild\u2010to\u2010moderate facial acne vulgaris","volume":"8","author":"Kircik LH","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_22_2","first-page":"1080","article-title":"Acne quality of life and patient satisfaction following treatment with tretinoin pump","volume":"8","author":"Fried R","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1994.01690030040006"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-3447"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1470.2012.01811.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1470.2012.01811.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T04:36:32Z","timestamp":1698640592000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1470.2012.01811.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,19]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1525-1470.2012.01811.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1470.2012.01811.x","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,19]]}}}